Industry Risk Profiles - August 23, 2026 - 8 min read
Section 232 Pharma Tariffs: The 29 September Deadline Indian API and CDMO Exporters Are Underestimating
From 29 September 2026, US Section 232 tariffs on patented pharmaceuticals and associated APIs reach 100% for importers with no approved onshoring plan and no qualifying origin. Indian API makers, CDMOs and licensors need to reprice trade credit limits, reread force majeure and price-adjustment clauses, and test whether cover responds if a US buyer refuses delivery on duty grounds.
By Sarvada Editorial Team